Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum CANEXUS CORP 6.5 PCT DEBS T.CUS.DB.D

TSX:CUS.DB.D - Post Discussion

CANEXUS CORP 6.5 PCT DEBS > Finally, the real story emerges today
View:
Post by phoenix_trader on Oct 19, 2016 9:04am

Finally, the real story emerges today

Last year, after a fulsome sale process, we agreed to be acquired by Superior at an implied value of $1.70 per Canexus share. It's important for you to understand that the sale process was a response to a non-binding and unsolicited proposal from Chemtrade at $1.90 per share, a proposal that Chemtrade neglected to mention in its take-over bid circular. Chemtrade also failed to mention that over the course of that process, on more than one occasion Chemtrade shifted the conditions on which it was willing to acquire your company, including significantly reducing the price at which it was prepared to transact. The Superior transaction failed to close for reasons beyond our control, being non-approval by the US Federal Trade Commission. But the value-maximization process that led to the Superior transaction was a clear demonstration of our willingness to transact at an appropriate price. Now, with all the improvements implemented since 2015, Canexus is worth more, not less. Your Board, after a full review and with the advice of external financial, legal and shareholder services advisors, recommends that shareholders reject the Chemtrade offer. Many large shareholders have indicated to us that they will not tender at $1.50 and no shareholders have indicated to us that they will tender at that price. By refusing to tender your shares, you send an important message: $1.50 per share isn't fair value.
Comment by MattMckienzes on Oct 19, 2016 9:06am
This post has been removed in accordance with Community Policy
Comment by phoenix_trader on Oct 19, 2016 9:08am
Murray shows his hand and I think we will see a $3 price within 18 months............Folks stand fast, and tell these sharks that a harpoon stands ready at the bow.
Comment by itsalie on Oct 19, 2016 9:52am
I bought some more this morning. average down a bit.. can't see it going any lower.. 
Comment by uograd on Oct 19, 2016 10:09am
that was certainly an interesting shot across the bow to read early this morning. I agree, $1.50 is not enough but $1.90 would work just fine. if chemtrade wants my shares ( and I Know they read this site) that is  the number. I also will be voting to kick this board out if the January meeting comes to fruition.  This company would be worth over $5.00 if they had not made the idiotic ...more  
Comment by MattMckienzes on Oct 19, 2016 1:21pm
This post has been removed in accordance with Community Policy
Comment by MattMckienzes on Oct 20, 2016 10:56am
This post has been removed in accordance with Community Policy